Humacyte, Inc. (HUMA) Executive Compensation
Humacyte, Inc. (HUMA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: HUMA
CIK: 1818382
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerAlex Vaughn
Audit LocationRaleigh, North Carolina, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-06 | 4 | 0001247296-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-10-07 | 2026-10-06 | 4 | 0002156537-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-09-28 | 2026-09-22 | 3 | 0002156537-26-000002 | View SEC Doc Filr Page |
| 3 | 2026-09-28 | 2026-09-22 | 3 | 0001247296-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-22 | 8-K | 0001818382-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-14 | 4 | 0001193125-26-391889 | View SEC Doc Filr Page |
| 25-NSE | 2026-08-25 | — | 25-NSE Filing | 0001354457-26-000819 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-20 | 4 | 0001193125-26-361081 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001193125-26-356847 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-08-18 | — | SCHEDULE 13D/A Filing | 0001104659-26-098152 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-347022 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | FORM 8-K | 0001104659-26-094440 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-31 | FORM 8-K | 0001104659-26-089281 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-28 | — | SCHEDULE 13G/A Filing | 0002012383-26-002519 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-13 | — | SCHEDULE 13D/A Filing | 0001104659-26-083164 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-22 | — | SCHEDULE 13G Filing | 0000919574-26-004065 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-06-15 | — | SCHEDULE 13D/A Filing | 0001104659-26-073827 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073620 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073617 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073616 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073615 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073614 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073613 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073611 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-11 | OWNERSHIP DOCUMENT | 0001104659-26-073610 | View SEC Doc Filr Page |